Target intelligence / Profile preview

Mucin polymer disulfide bridge (null)

Target
null
Molecular classification
Other, structural motif, posttranslational modification, Not a unique gene/protein, receptor, enzyme, etc.
01

Overview

Mucin polymer disulfide bridges are covalent bonds formed between cysteine residues of mucin polypeptides, enabling the polymerization of secreted mucins such as MUC2, MUC5AC, and MUC5B into large, gel-forming networks that constitute mucus on respiratory, gastrointestinal, and other mucosal surfaces[1][2][3][4][5][6]. These disulfide bridges are crucial for producing the viscoelastic and barrier properties of mucus. The process occurs during mucin biosynthesis in the secretory pathway, is regulated by pH and calcium, and is responsible for cross-linking mucin monomers into functional polymers. Dysfunctional formation or abnormal reduction of these bridges alters mucus structure and is implicated in various diseases characterized by impaired or excessive mucus, such as cystic fibrosis, COPD, and certain intestinal disorders[2][4][5][6].

Other names
Disulfide bond in mucin polymerMucin intermolecular disulfide bridgeMucin N-terminal/C-terminal disulfide bonds
02

Mechanism of action

Reducing agents (e.g., N-acetylcysteine) may cleave disulfide bonds in mucin polymers, reducing mucus viscosity indirectly. Inhibitors of mucin secretion may reduce overall polymer formation.

03

Biological functions

Mucin polymerizationStructural stabilization of mucusFormation of mucus gelBarrier protection of mucosal surfaces
04

Disease associations

OtherCystic fibrosisChronic obstructive pulmonary disease (COPD)AsthmaInflammatory bowel disease
05

Safety considerations

Cleavage of mucin disulfide bridges decreases mucus viscosity. Over-cleavage may compromise the protective mucosal barrier, increasing infection risk.General lack of specificity for pharmacological intervention at the disulfide bond level.
06

Biomarkers

None specific to disulfide bridges. Mucin protein levels (e.g., MUC5AC, MUC5B) may serve as disease biomarkers.

Beyond the preview

Go deeper on Mucin polymer disulfide bridge (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucin polymer disulfide bridge (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call